Bringing organ preservation closer for selected patients with rectal cancer

Affiliations

¹ Department of Surgery, Catharina Hospital, Eindhoven 5623 E, Netherlands; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, Netherlands. Electronic address: harm.rutten@catharinaziekenhuis.nl.
² Department of Surgery, Catharina Hospital, Eindhoven 5623 E, Netherlands.

Comment

Harm J T Rutten et al. Lancet Gastroenterol Hepatol. 2023 Apr.

. 2023 Apr;8(4):294-295.

doi: 10.1016/S2468-1253(22)00438-1. Epub 2023 Feb 16.

¹ Department of Surgery, Catharina Hospital, Eindhoven 5623 E, Netherlands; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, Netherlands. Electronic address: harm.rutten@catharinaziekenhuis.nl.
² Department of Surgery, Catharina Hospital, Eindhoven 5623 E, Netherlands.

No abstract available

Conflict of interest statement

We declare no competing interests.

Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial.
Gerard JP, Barbet N, Schiappa R, Magné N, Martel I, Mineur L, Deberne M, Zilli T, Dhadda A, Myint AS; ICONE group. Gerard JP, et al. Lancet Gastroenterol Hepatol. 2023 Apr;8(4):356-367. doi: 10.1016/S2468-1253(22)00392-2. Epub 2023 Feb 16. Lancet Gastroenterol Hepatol. 2023. PMID: 36801007 Clinical Trial.